Interventional management of resistant hypertension

@article{Doumas2009InterventionalMO,
  title={Interventional management of resistant hypertension},
  author={Michael Doumas and Stella Douma},
  journal={The Lancet},
  year={2009},
  volume={373},
  pages={1228-1230}
}
Hypertension is one of the most popular fields of re-search in modern medicine due to its high prevalence and its major impact on cardiovascular risk and con-sequently on global health. Indeed, about one third of individuals worldwide has hypertension and is under increased long-term risk of myocardial infarction, stroke or cardiovascular death. On the other hand, resistant hypertension, the 'uncontrollable' part of arterial hy-pertension despite appropriate therapy, comprises a much greater… Expand
Novel Therapies for Resistant Hypertension
TLDR
Two novel invasive therapeutic strategies for the treatment of resistant hypertension, carotid baroreceptor stimulation and renal denervation are effective in reducing elevated blood pressure values and display a good tolerability profile without the occurrence of any major untoward effect. Expand
THE ROLE OF RENAL SYMPATHETIC NERVES IN THE PATHOGENESIS OF HYPERTENSION
D espite continued advances in its diagnosis, treatment, and public awareness, hypertension continues to affect cardiovascular health. Hypertension is a significant risk factor for stroke, coronaryExpand
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
TLDR
This special issue of the journal expoars a whole spectrum of topics related to resistant hypertension: several articles address pathophysiolog and secondary causes of resistant hypertension and modern approaches to therapy, including the referance to the newer interventional approaches, that is, Baroreceptor stimulation therapy and catheter based sympathetic renal denervation. Expand
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
TLDR
The pathophysiology of kidney function, interaction and crosstalk between the kidney and the brain, justifies the use of renal sympathetic denervation in the treatment of hypertension and considers several future potential applications. Expand
Renal sympathetic denervation in hypertension
TLDR
The aim of this review is to present the pathophysiologic background and the mechanisms mediating blood pressure reduction after renal sympathetic denervation, to analyze recent findings with this fascinating approach and to critically suggest future research directions. Expand
Renal denervation for treatment-resistant hypertension
TLDR
This review provides a detailed overview on the history of hypertension, treatment-resistant hypertension, the rationale behind RSD, current evidence and potential future applications of RSD. Expand
resistant Hypertension : clinical considerations and the Potential for renal denervation
cover story R esistant hypertension (RHTN) is commonly defined as the presence of uncontrolled blood pressure (BP) (systolic BP > 140 mm Hg or dia-stolic BP > 90 mm Hg) despite appropriate lifestyleExpand
Appraisal of the Clinical Trial Data on Renal Denervation for the Management of Resistant Hypertension
TLDR
RHTN should not be confused with uncontrolled HTN, the latter being an umbrella term to include all those individuals unable to achieve adequate BP targets, including that due to non-adherence, despite therapeutic intervention. Expand
Renal Sympathetic Denervation Therapy for Resistant Hypertension: A Contemporary Synopsis and Future Implications
TLDR
This review focuses on the evolution of renal sympathetic denervation (RSDN) therapy; its role in the management of RHTN; current trial data; the wider application of renal denervation in the treatment of heart failure, arrhythmia, and the metabolic syndrome; and emerging technologies for this potential device-based standard of care. Expand
Catheter-based renal denervation for treatment of resistant hypertension
TLDR
Reduction of renal sympathetic activity by percutaneous catheter-based radiofrequency ablation via the renal arteries has been shown in several studies to decrease blood pressure in patients with resistant hypertension, and importantly is largely free of significant complications. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 13 REFERENCES
Resistant hypertension: an overview of evaluation and treatment.
TLDR
Education and reinforcement of life-style issues that affect BP, such as sodium restriction, reduction of alcohol intake, and weight loss if obese, are critical in treating resistant hypertension, and an antihypertensive treatment regimen is used that focuses on the genesis of the hypertension. Expand
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
TLDR
Expanding the understanding of the causes of resistant hypertension and thereby potentially allowing for more effective prevention and/or treatment will be essential to improve the long-term clinical management of this disorder. Expand
Evaluation and Treatment of Resistant or Difficult‐to‐Control Hypertension
TLDR
Patients referred for resistant or difficult‐to‐control hypertension may be controlled by making targeted adjustments to their medical regimen by using a combination of diuretic and antihypertensive medications. Expand
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
TLDR
Catheter-based renal denervation causes substantial and sustained blood-pressure reduction, without serious adverse events, in patients with resistant hypertension, in a proof-of-principle trial of therapeutic renal sympathetic denervation. Expand
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
TLDR
The prevalence of primary hyperaldosteronism in patients with resistant hypertension was high, and it was substantially lower than previously reported, suggesting that the notion of an epidemic of primaryhyperaldoster onism in the general unselected hypertensive population is not supported. Expand
Efficacy of low-dose spironolactone in subjects with resistant hypertension.
TLDR
It is concluded that low-dose spironolactone provides significant additive BP reduction in African American and white subjects with resistant hypertension with and without primary aldosteronism. Expand
Results of bilateral supradiaphragmatic splanchnicectomy for arterial hypertension.
  • M. M. Peet
  • Medicine
  • The New England journal of medicine
  • 1947
TLDR
Arterial hypertension, usually designated as essential hypertension, is a highly complex disease syndrome, which encompasses the extremes from a fatal termination in a few months to a seemingly benign course of many years. Expand
Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions
TLDR
The carotid baroreceptor reflex is probably not completely in control of blood pressure, and the development of a new device (Rheos®) that addresses problems with older devices is described. Expand
Levels of Renal and Extrarenal Sympathetic Drive in Angiotensin II-Induced Hypertension
TLDR
The greater depressor effect of acute ganglion blockade in hypertensive rabbits suggests that the sympathetic nervous system exerts increased vasoconstriction in the peripheral vasculature in Ang II-induced hypertension. Expand
Serum total homocysteine, folate, 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T genotype and subclinical atherosclerosis
TLDR
Measurements of blood levels of homocysteine and folate in people at intermediate risk for atherosclerotic CVD before symptoms occur, might improve risk stratification and facilitate the decision to provide folate/B vitamin intervention in primary prevention. Expand
...
1
2
...